We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development.
- Authors
Diamond, Matthew L.; Ritter, Anne C.; Jackson, Edwin K.; Conley, Yvette P.; Kochanek, Patrick M.; Boison, Detlev; Wagner, Amy K.
- Abstract
Objective Determine if genetic variation in enzymes/transporters influencing extracellular adenosine homeostasis, including adenosine kinase ( ADK), [ecto-5′-nucleotidase ( NT5E), cluster of differentiation 73 ( CD73)], and equilibrative nucleoside transporter type-1 ( ENT-1), is significantly associated with epileptogenesis and posttraumatic epilepsy ( PTE) risk, as indicated by time to first seizure analyses. Methods Nine ADK, three CD73, and two ENT-1 tagging single nucleotide polymorphisms (SNPs) were genotyped in 162 white adults with moderate/severe traumatic brain injury (TBI) and no history of premorbid seizures. Kaplan-Meier models were used to screen for genetic differences in time to first seizure occurring >1 week post- TBI. SNPs remaining significant after correction for multiple comparisons were examined using Cox proportional hazards analyses, adjusting for subdural hematoma, injury severity score, and isolated TBI status. SNPs significant in multivariate models were then entered simultaneously into an adjusted Cox model. Results Comparing Kaplan-Meier curves, rs11001109 ( ADK) rare allele homozygosity and rs9444348 ( NT5E) heterozygosity were significantly associated with shorter time to first seizure and an increased seizure rate 3 years post- TBI. Multivariate Cox proportional hazard models showed that these genotypes remained significantly associated with increased PTE hazard up to 3 years post- TBI after controlling for variables of interest (rs11001109: hazard ratio (HR) 4.47, 95% confidence interval ( CI) 1.27-15.77, p = 0.020; rs9444348: HR 2.95, 95% CI 1.19-7.31, p = 0.019) . Significance Genetic variation in ADK and NT5E may help explain variability in time to first seizure and PTE risk, independent of previously identified risk factors, after TBI. Once validated, identifying genetic variation in adenosine regulatory pathways relating to epileptogenesis and PTE may facilitate exploration of therapeutic targets and pharmacotherapy development.
- Subjects
GENETICS of epilepsy; BRAIN injuries; PHYSIOLOGICAL effects of adenosine; ADENOSINE kinase; SINGLE nucleotide polymorphisms; DEPHOSPHORYLATION; NUCLEOTIDASES
- Publication
Epilepsia (Series 4), 2015, Vol 56, Issue 8, p1198
- ISSN
0013-9580
- Publication type
Article
- DOI
10.1111/epi.13044